Anagenics (AN1) Stock Statistics & Valuation Metrics

Anagenics has a market cap or net worth of AU$5.91M. The enterprise value is AU$3.33M.

Anagenics has 985,450,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Anagenics ’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -49.34%.

The current PE Ratio of Anagenics is 5.6. Anagenics ’s PEG ratio is 0.02.

In the last 12 months, Anagenics had revenue of 4.75M and earned -1.24M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -942.12K and capital expenditures -11.30K, giving a free cash flow of -953.41K billion.

Anagenics pays an annual dividend of ―, resulting in a dividend yield of ―

Anagenics upcoming earnings date is Sep 2, 2026, TBA (Confirmed).

Anagenics as a current ratio of 0.89, with Debt / Equity ratio of 43.43%

In the past 12 months, Anagenics has paid 0.00 in taxes.

Anagenics EV to EBITDA ratio is -2.81, with an EV/FCF ratio of -1.78.

Anagenics has AU$294.30K in cash and marketable securities with AU$986.80K in debt, giving a net cash position of -AU$692.50K billion.

Gross margin is 44.72%, with operating margin of -27.80%, and net profit margin of -26.04%.

The average price target for Anagenics is ―, which is 11.43% higher than the current price. The consensus rating is ―